Franz Obermayr

Company: EPICS Therapeutics

Job title: Chief Executive Officer

Seminars:

Roundtable: Discussing the Different Strategies & Approaches of Translating Binding & Functionality Effects to the Clinic 2:00 pm

Understanding tonality and the evolution of novel small molecule inhibitors for improved efficacy in in vivo models What are the current strategies and approaches to successfully translate functionality into the clinic and how can these be improved?Read more

day: Day Two

Discussing Novel Best-in-Class Inhibitors of RNA Modifying Enzymes in Oncology for Preclinical Progression 1:30 pm

Targeting different RNA modifying enzymes using in-house established discovery platform to identify and develop novel highly specific small molecule inhibitors for advanced translation and progression into clinic Exploring case studies of preclinical programs of the best, first in class molecules in oncology with the goal of providing novel therapeutic approaches for patients with unmet medical…Read more

day: Day Two